145 related articles for article (PubMed ID: 1721274)
1. Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.
Jain AB; Venkataramanan R; Fung J; Burckart G; Emeigh J; Diven W; Warty V; Abu-Elmagd K; Todo S; Alessiani M
Transplant Proc; 1991 Dec; 23(6):2777-9. PubMed ID: 1721274
[No Abstract] [Full Text] [Related]
2. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Wahlstrom HE; Sanchez-Urdazpal L; Richards T; Crotty P; Beaver S
Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
[No Abstract] [Full Text] [Related]
3. Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
McCauley J; Fung JJ; Brown H; Deballi P; Jain A; Todo S; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3148-9. PubMed ID: 1721387
[No Abstract] [Full Text] [Related]
4. Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.
Felser I; Wagner S; Depee J; Johnson N; Staschak S; Jain A; Fung JJ; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3032-4. PubMed ID: 1721350
[No Abstract] [Full Text] [Related]
5. A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation.
McDiarmid SV; Colonna JO; Shaked A; Ament ME; Busuttil RW
Transplantation; 1993 Oct; 56(4):847-53. PubMed ID: 7692636
[TBL] [Abstract][Full Text] [Related]
6. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
[No Abstract] [Full Text] [Related]
7. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients.
Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
Transpl Int; 1994; 7 Suppl 1():S52-7. PubMed ID: 11271297
[TBL] [Abstract][Full Text] [Related]
10. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.
Freise CE; Rowley H; Lake J; Hebert M; Ascher NL; Roberts JP
Transplant Proc; 1991 Dec; 23(6):3173-4. PubMed ID: 1721397
[No Abstract] [Full Text] [Related]
11. Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.
Jain AB; Fung JJ; Tzakis AG; Venkataramanan R; Abu-Elmagd K; Alessiani M; Reyes J; Irish W; Warty V; Mehta S
Transplant Proc; 1991 Dec; 23(6):2763-6. PubMed ID: 1721270
[No Abstract] [Full Text] [Related]
12. FK 506 versus cyclosporine in pediatric liver transplantation.
Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
[No Abstract] [Full Text] [Related]
13. Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity.
Khalaf H; Al-Asseri A; Bhuiyan J; Nafea O; Al-Sebayel M
Transplant Proc; 2003 Nov; 35(7):2787-8. PubMed ID: 14612120
[No Abstract] [Full Text] [Related]
14. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506.
Mor E; Patel T; Glabman S; Sheiner P; Emre S; Guy S; Schwartz M; Miller C
Transpl Int; 1994; 7 Suppl 1():S77-80. PubMed ID: 11271340
[TBL] [Abstract][Full Text] [Related]
15. Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.
Winkler M; Jost U; Ringe B; Gubernatis G; Wonigeit K; Pichlmayr R
Transplant Proc; 1991 Dec; 23(6):3153-5. PubMed ID: 1721389
[No Abstract] [Full Text] [Related]
16. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
[No Abstract] [Full Text] [Related]
17. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Abouljoud MS; Levy MF; Klintmalm GB
Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360
[No Abstract] [Full Text] [Related]
18. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Bismuth H
Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
[No Abstract] [Full Text] [Related]
19. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
Porayko MK; Gonwa TA; Klintmalm GB; Wiesner RH
Transplant Proc; 1995 Feb; 27(1):1114-6. PubMed ID: 7533358
[No Abstract] [Full Text] [Related]
20. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
